Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
Ryan PelletierPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
The Khorana Risk Score was the chosen model used for the pharmacist-led VTE risk assessment program due to its user-friendly scoring algorithm, evidence from validation studies and clinical trials, as well as ease of integration into pharmacy workflow. More research is needed to determine if pharmacist-led VTE risk assessment programs will impact patient outcomes, such as morbidity and mortality, secondary to cancer-associated thrombosis.
Keyphrases
- venous thromboembolism
- risk assessment
- direct oral anticoagulants
- quality improvement
- clinical trial
- human health
- blood pressure
- heavy metals
- primary care
- papillary thyroid
- machine learning
- healthcare
- public health
- pulmonary embolism
- deep learning
- squamous cell
- squamous cell carcinoma
- phase ii
- climate change
- young adults
- lymph node metastasis